Advertisement
Screener

UTAH MEDICAL PRODUCTS, INC. (UTMD) Operating Income

UTAH MEDICAL PRODUCTS, INC. Operating Income

UTAH MEDICAL PRODUCTS, INC. (UTMD) reported Operating Income of $2.65 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.

Financial Statements › Income Statement

us-gaap:OperatingIncomeLoss · last filed 2026-08-12

  • UTAH MEDICAL PRODUCTS, INC. operating income (loss) for the quarter ending 2026-06-30 was $2.65M, a 17.12% decline year-over-year.
  • UTAH MEDICAL PRODUCTS, INC. operating income (loss) for the quarter ending 2026-03-31 was $2.56M, a 18.65% decline year-over-year.
  • UTAH MEDICAL PRODUCTS, INC. operating income (loss) for the quarter ending 2025-12-31 was $2.44M, a 16.69% decline year-over-year.
  • UTAH MEDICAL PRODUCTS, INC. operating income (loss) for the quarter ending 2025-09-30 was $2.61M, a 21.90% decline year-over-year.
  • UTAH MEDICAL PRODUCTS, INC. operating income (loss) for fiscal 2025 was $11.40M, a 16.12% decline from fiscal 2024.
  • UTAH MEDICAL PRODUCTS, INC. operating income (loss) for fiscal 2024 was $13.59M, a 18.97% decline from fiscal 2023.
  • UTAH MEDICAL PRODUCTS, INC. operating income (loss) for fiscal 2023 was $16.78M, a 15.22% decline from fiscal 2022.
  • UTAH MEDICAL PRODUCTS, INC. operating income (loss) for fiscal 2022 was $19.79M, a 4.82% increase from fiscal 2021.
Period endOperating Income (Loss) 3 monthOperating Income (Loss) 6 monthOperating Income (Loss) 9 monthOperating Income (Loss) 12 month
2026-06-30$2.65M
10-Q · filed 2026-08-12
$5.21M
10-Q · filed 2026-08-12
$7.66M
derived: sum of 3 quarters · filed 2026-08-12
$10.27M
derived: sum of 4 quarters · filed 2026-08-12
2026-03-31$2.56M
10-Q · filed 2026-05-12
$5.01M
derived: sum of 2 quarters · filed 2026-05-12
$7.62M
derived: sum of 3 quarters · filed 2026-05-12
$10.81M
derived: sum of 4 quarters · filed 2026-08-12
2025-12-31$2.44M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27
$5.05M
derived: sum of 2 quarters · filed 2026-03-27
$8.25M
derived: sum of 3 quarters · filed 2026-08-12
$11.40M
10-K · filed 2026-03-27
2025-09-30$2.61M
10-Q · filed 2025-11-14
$5.81M
derived: sum of 2 quarters · filed 2026-08-12
$8.96M
10-Q · filed 2025-11-14
$11.89M
derived: sum of 4 quarters · filed 2026-08-12
2025-06-30$3.20M
10-Q · filed 2026-08-12
$6.35M
10-Q · filed 2026-08-12
$9.28M
derived: sum of 3 quarters · filed 2026-08-12
$12.62M
derived: sum of 4 quarters · filed 2026-08-12
2025-03-31$3.15M
10-Q · filed 2026-05-12
$6.08M
derived: sum of 2 quarters · filed 2026-05-12
$9.43M
derived: sum of 3 quarters · filed 2026-05-12
$12.86M
derived: sum of 4 quarters · filed 2026-05-12
2024-12-31$2.93M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27
$6.27M
derived: sum of 2 quarters · filed 2026-03-27
$9.71M
derived: sum of 3 quarters · filed 2026-03-27
$13.59M
10-K · filed 2026-03-27
2024-09-30$3.34M
10-Q · filed 2025-11-14
$6.78M
derived: sum of 2 quarters · filed 2025-11-14
$10.66M
10-Q · filed 2025-11-14
$14.61M
derived: sum of 4 quarters · filed 2026-03-27
2024-06-30$3.44M
10-Q · filed 2025-08-12
$7.32M
10-Q · filed 2025-08-12
$11.27M
derived: sum of 3 quarters · filed 2026-03-27
$15.23M
derived: sum of 4 quarters · filed 2026-03-27
2024-03-31$3.88M
10-Q · filed 2025-05-15
$7.83M
derived: sum of 2 quarters · filed 2026-03-27
$11.80M
derived: sum of 3 quarters · filed 2026-03-27
$16.22M
derived: sum of 4 quarters · filed 2026-03-27
2023-12-31$3.94M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27
$7.91M
derived: sum of 2 quarters · filed 2026-03-27
$12.34M
derived: sum of 3 quarters · filed 2026-03-27
$16.78M
10-K · filed 2026-03-27
2023-09-30$3.97M
10-Q · filed 2024-11-12
$8.39M
derived: sum of 2 quarters · filed 2024-11-12
$12.83M
10-Q · filed 2024-11-12
$17.90M
derived: sum of 4 quarters · filed 2025-03-26
2023-06-30$4.42M
10-Q · filed 2024-08-09
$8.86M
10-Q · filed 2024-08-09
$13.93M
derived: sum of 3 quarters · filed 2025-03-26
$19.07M
derived: sum of 4 quarters · filed 2025-03-26
2023-03-31$4.44M
10-Q · filed 2024-05-10
$9.51M
derived: sum of 2 quarters · filed 2025-03-26
$14.65M
derived: sum of 3 quarters · filed 2025-03-26
$19.71M
derived: sum of 4 quarters · filed 2025-03-26
2022-12-31$5.07M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26
$10.21M
derived: sum of 2 quarters · filed 2025-03-26
$15.27M
derived: sum of 3 quarters · filed 2025-03-26
$19.79M
10-K · filed 2025-03-26
2022-09-30$5.14M
10-Q · filed 2023-11-13
$10.20M
derived: sum of 2 quarters · filed 2023-11-13
$14.72M
10-Q · filed 2023-11-13
$19.85M
derived: sum of 4 quarters · filed 2024-03-26
2022-06-30$5.06M
10-Q · filed 2023-08-11
$9.58M
10-Q · filed 2023-08-11
$14.71M
derived: sum of 3 quarters · filed 2024-03-26
$19.81M
derived: sum of 4 quarters · filed 2024-03-26
2022-03-31$4.52M
10-Q · filed 2023-05-05
$9.65M
derived: sum of 2 quarters · filed 2024-03-26
$14.75M
derived: sum of 3 quarters · filed 2024-03-26
$19.52M
derived: sum of 4 quarters · filed 2024-03-26
2021-12-31$5.13M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26
$10.23M
derived: sum of 2 quarters · filed 2024-03-26
$14.99M
derived: sum of 3 quarters · filed 2024-03-26
$18.88M
10-K · filed 2024-03-26
2021-09-30$5.10M
10-Q · filed 2022-11-10
$9.86M
derived: sum of 2 quarters · filed 2022-11-10
$13.75M
10-Q · filed 2022-11-10
$18.03M
derived: sum of 4 quarters · filed 2023-03-28
2021-06-30$4.76M
10-Q · filed 2022-08-12
$8.65M
10-Q · filed 2022-08-12
$12.93M
derived: sum of 3 quarters · filed 2023-03-28
$16.52M
derived: sum of 4 quarters · filed 2023-03-28
2021-03-31$3.89M
10-Q · filed 2022-05-11
$8.17M
derived: sum of 2 quarters · filed 2023-03-28
$11.76M
derived: sum of 3 quarters · filed 2023-03-28
$13.73M
derived: sum of 4 quarters · filed 2023-03-28
2020-12-31$4.28M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-28
$7.87M
derived: sum of 2 quarters · filed 2023-03-28
$9.84M
derived: sum of 3 quarters · filed 2023-03-28
$13.71M
10-K/A · filed 2023-03-28
2020-09-30$3.59M
10-Q · filed 2021-11-12
$5.56M
derived: sum of 2 quarters · filed 2021-11-12
$9.43M
10-Q · filed 2021-11-12
$14.11M
derived: sum of 4 quarters · filed 2022-03-25
2020-06-30$1.98M
10-Q · filed 2021-08-06
$5.84M
10-Q · filed 2021-08-06
$10.52M
derived: sum of 3 quarters · filed 2022-03-25
$14.89M
derived: sum of 4 quarters · filed 2022-03-25
2020-03-31$3.86M
10-Q · filed 2021-05-11
$8.54M
derived: sum of 2 quarters · filed 2022-03-25
$12.91M
derived: sum of 3 quarters · filed 2022-03-25
$17.39M
derived: sum of 4 quarters · filed 2022-03-25
2019-12-31$4.68M
derived: 10-K 12 month − 10-Q/A 9 month · filed 2022-03-25
$9.05M
derived: sum of 2 quarters · filed 2022-03-25
$13.53M
derived: sum of 3 quarters · filed 2022-03-25
$17.63M
10-K · filed 2022-03-25
2019-09-30$4.37M
10-Q/A · filed 2020-11-09
$8.85M
derived: sum of 2 quarters · filed 2020-11-09
$12.95M
10-Q/A · filed 2020-11-09
$17.22M
derived: sum of 4 quarters · filed 2021-03-26
2019-06-30$4.48M
10-Q · filed 2020-08-07
$8.58M
10-Q · filed 2020-08-07
$12.85M
derived: sum of 3 quarters · filed 2021-03-26
$17.25M
derived: sum of 4 quarters · filed 2021-03-26
2019-03-31$4.10M
10-Q · filed 2020-05-08
$8.37M
derived: sum of 2 quarters · filed 2021-03-26
$12.77M
derived: sum of 3 quarters · filed 2021-03-26
$17.83M
derived: sum of 4 quarters · filed 2021-03-26
2018-12-31$4.27M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-26
$8.67M
derived: sum of 2 quarters · filed 2021-03-26
$13.73M
derived: sum of 3 quarters · filed 2021-03-26
$18.70M
10-K · filed 2021-03-26
2018-09-30$4.40M
10-Q · filed 2019-11-07
$9.46M
derived: sum of 2 quarters · filed 2019-11-07
$14.43M
10-Q · filed 2019-11-07
$19.00M
derived: sum of 4 quarters · filed 2020-03-16
2018-06-30$5.06M
10-Q · filed 2019-08-09
$10.03M
10-Q · filed 2019-08-09
$14.60M
derived: sum of 3 quarters · filed 2020-03-16
$19.28M
derived: sum of 4 quarters · filed 2020-03-16
2018-03-31$4.97M
10-Q · filed 2019-05-09
$9.54M
derived: sum of 2 quarters · filed 2020-03-16
$14.22M
derived: sum of 3 quarters · filed 2020-03-16
$19.26M
derived: sum of 4 quarters · filed 2020-03-16
2017-12-31$4.57M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16
$9.25M
derived: sum of 2 quarters · filed 2020-03-16
$14.29M
derived: sum of 3 quarters · filed 2020-03-16
$19.01M
10-K · filed 2020-03-16
2017-09-30$4.68M
10-Q · filed 2018-11-07
$9.71M
derived: sum of 2 quarters · filed 2018-11-07
$14.44M
10-Q · filed 2018-11-07
$18.06M
derived: sum of 4 quarters · filed 2019-03-14
2017-06-30$5.03M
10-Q · filed 2018-08-09
$9.76M
10-Q · filed 2018-08-09
$13.38M
derived: sum of 3 quarters · filed 2019-03-14
$17.32M
derived: sum of 4 quarters · filed 2019-03-14
2017-03-31$4.72M
10-Q · filed 2018-05-09
$8.35M
derived: sum of 2 quarters · filed 2019-03-14
$12.29M
derived: sum of 3 quarters · filed 2019-03-14
$16.60M
derived: sum of 4 quarters · filed 2019-03-14
2016-12-31$3.62M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14
$7.56M
derived: sum of 2 quarters · filed 2019-03-14
$11.88M
derived: sum of 3 quarters · filed 2019-03-14
$16.19M
10-K · filed 2019-03-14
2016-09-30$3.94M
10-Q · filed 2017-11-07
$8.25M
derived: sum of 2 quarters · filed 2017-11-07
$12.57M
10-Q · filed 2017-11-07
$16.37M
derived: sum of 4 quarters · filed 2018-03-06
2016-06-30$4.32M
10-Q · filed 2017-08-03
$8.63M
10-Q · filed 2017-08-03
$12.43M
derived: sum of 3 quarters · filed 2018-03-06
$16.43M
derived: sum of 4 quarters · filed 2018-03-06
2016-03-31$4.31M
10-Q · filed 2017-05-05
$8.12M
derived: sum of 2 quarters · filed 2018-03-06
$12.12M
derived: sum of 3 quarters · filed 2018-03-06
$16.09M
derived: sum of 4 quarters · filed 2018-03-06
2015-12-31$3.81M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06
$7.81M
derived: sum of 2 quarters · filed 2018-03-06
$11.77M
derived: sum of 3 quarters · filed 2018-03-06
$15.65M
10-K · filed 2018-03-06
2015-09-30$4.00M
10-Q · filed 2016-11-04
$7.97M
derived: sum of 2 quarters · filed 2016-11-04
$11.85M
10-Q · filed 2016-11-04
$16.14M
derived: sum of 4 quarters · filed 2017-03-08
2015-06-30$3.97M
10-Q · filed 2016-08-08
$7.84M
10-Q · filed 2016-08-08
$12.14M
derived: sum of 3 quarters · filed 2017-03-08
$16.14M
derived: sum of 4 quarters · filed 2017-03-08
2015-03-31$3.88M
10-Q · filed 2016-05-06
$8.17M
derived: sum of 2 quarters · filed 2017-03-08
$12.17M
derived: sum of 3 quarters · filed 2017-03-08
$16.24M
derived: sum of 4 quarters · filed 2017-03-08
2014-12-31$4.29M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-08
$8.30M
derived: sum of 2 quarters · filed 2017-03-08
$12.36M
derived: sum of 3 quarters · filed 2017-03-08
$16.20M
10-K · filed 2017-03-08
2014-09-30$4.00M
10-Q · filed 2015-11-06
$8.06M
derived: sum of 2 quarters · filed 2015-11-06
$11.91M
10-Q · filed 2015-11-06
$15.47M
derived: sum of 4 quarters · filed 2016-03-10
2014-06-30$4.06M
10-Q · filed 2015-08-07
$7.91M
10-Q · filed 2015-08-07
$11.46M
derived: sum of 3 quarters · filed 2016-03-10
$15.13M
derived: sum of 4 quarters · filed 2016-03-10
2014-03-31$3.84M
10-Q · filed 2015-05-06
$7.40M
derived: sum of 2 quarters · filed 2016-03-10
$11.07M
derived: sum of 3 quarters · filed 2016-03-10
$14.78M
derived: sum of 4 quarters · filed 2016-03-10
2013-12-31$3.56M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10
$7.22M
derived: sum of 2 quarters · filed 2016-03-10
$10.94M
derived: sum of 3 quarters · filed 2016-03-10
$14.83M
10-K · filed 2016-03-10
2013-09-30$3.67M
10-Q · filed 2014-11-04
$7.38M
derived: sum of 2 quarters · filed 2014-11-04
$11.27M
10-Q · filed 2014-11-04
$14.84M
derived: sum of 4 quarters · filed 2015-03-12
2013-06-30$3.71M
10-Q · filed 2014-08-08
$7.61M
10-Q · filed 2014-08-08
$11.17M
derived: sum of 3 quarters · filed 2015-03-12
$15.13M
derived: sum of 4 quarters · filed 2015-03-12
2013-03-31$3.89M
10-Q · filed 2014-05-07
$7.46M
derived: sum of 2 quarters · filed 2015-03-12
$11.42M
derived: sum of 3 quarters · filed 2015-03-12
$14.97M
derived: sum of 4 quarters · filed 2015-03-12
2012-12-31$3.57M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12
$7.53M
derived: sum of 2 quarters · filed 2015-03-12
$11.08M
derived: sum of 3 quarters · filed 2015-03-12
$15.20M
10-K · filed 2015-03-12
2012-09-30$3.96M
10-Q · filed 2013-11-06
$7.51M
derived: sum of 2 quarters · filed 2013-11-06
$11.63M
10-Q · filed 2013-11-06
$14.54M
derived: sum of 4 quarters · filed 2014-03-12
2012-06-30$3.55M
10-Q · filed 2013-08-08
$7.67M
10-Q · filed 2013-08-08
$10.58M
derived: sum of 3 quarters · filed 2014-03-12
$14.12M
derived: sum of 4 quarters · filed 2014-03-12
2012-03-31$4.12M
10-Q · filed 2013-05-08
$7.03M
derived: sum of 2 quarters · filed 2014-03-12
$10.57M
derived: sum of 3 quarters · filed 2014-03-12
$13.80M
derived: sum of 4 quarters · filed 2014-03-12
2011-12-31$2.91M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-12
$6.45M
derived: sum of 2 quarters · filed 2014-03-12
$9.69M
derived: sum of 3 quarters · filed 2014-03-12
$11.84M
10-K · filed 2014-03-12
2011-09-30$3.54M
10-Q · filed 2012-11-09
$6.77M
derived: sum of 2 quarters · filed 2012-11-09
$8.93M
10-Q · filed 2012-11-09
$11.11M
derived: sum of 4 quarters · filed 2013-03-07
2011-06-30$3.23M
10-Q · filed 2012-08-08
$5.39M
10-Q · filed 2012-08-08
$7.57M
derived: sum of 3 quarters · filed 2013-03-07
$9.83M
derived: sum of 4 quarters · filed 2013-03-07
2011-03-31$2.16M
10-Q · filed 2012-05-09
$4.34M
derived: sum of 2 quarters · filed 2013-03-07
$6.60M
derived: sum of 3 quarters · filed 2013-03-07
$8.79M
derived: sum of 4 quarters · filed 2013-03-07
2010-12-31$2.18M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-07
$4.44M
derived: sum of 2 quarters · filed 2013-03-07
$6.63M
derived: sum of 3 quarters · filed 2013-03-07
$8.92M
10-K · filed 2013-03-07
2010-09-30$2.26M
10-Q · filed 2011-11-07
$4.45M
derived: sum of 2 quarters · filed 2011-11-07
$6.74M
10-Q · filed 2011-11-07
2010-06-30$2.19M
10-Q · filed 2011-08-08
$4.48M
10-Q · filed 2011-08-08
2009-12-31$9.43M
10-K/A · filed 2012-10-25

Similar stocks

Stock NameCountryMarket CapPE Ratio
PRO DEX INC (PDEX)United States$0.234B13.64
InfuSystem Holdings, Inc (INFU)United States$0.253B22.52
Neuronetics, Inc. (STIM)United States$0.216B-3.25
Profound Medical Corp. (PROF)$0.206B-7.37
Anika Therapeutics, Inc. (ANIK)United States$0.272B-51.71
ORASURE TECHNOLOGIES INC (OSUR)United States$0.272B-6.26
Cytosorbents Corp (CTSO)United States$0.274B-1.29
TriSalus Life Sciences, Inc. (TLSI)United States$0.283B-9.92
Mobia Medical, Inc. (MOBI)United States$0.293B
TREACE MEDICAL CONCEPTS, INC. (TMCI)United States$0.297B-4.32